Recent progress in studies on direct cell-fate conversion of differentiated somatic cells into other cell types, which is known as "direct reprogramming", is expected to lead to innovations in health care. In our previous study, we found that three specific combinations of two transcription factors, comprising Hnf4α plus Foxa1, Foxa2, or Foxa3, were able to induce conversion of mouse fibroblasts into functional hepatocyte-like cells. These induced hepatocyte-like (iHep) cells will be useful for developing regenerative therapies for liver diseases and examining the pharmacological effects of drugs. However, to evaluate the potential utility of iHep cells, the phenomena involved in the direct conversion of fibroblasts into iHep cells should be examined in detail. Thus, in this study, we sequentially analyzed the early stage of fibroblast conversion into iHep cells after infection with retroviruses expressing Hnf4α and Foxa3. Our data demonstrated that the conversion into iHep cells began within 2 days after introduction of the transgenes into fibroblasts, and the number of iHep cells increased gradually as the culture progressed. The rapid cell-fate conversion of fibroblasts into iHep cells and stable expansion of iHep cells are two pieces of evidence suggesting the utility of iHep cells for cell transplantation therapy, bioartificial liver development, and screening of drugs for patients with liver diseases, which require many hepatocytes within a short period of time.
Introduction
Hepatocytes, which compose nearly 80% of the liver mass, play important roles in the maintenance of its vital functions, including protein synthesis, detoxification, lipid metabolism, and carbohydrate metabolism. Thus, for treatment of liver diseases by cell-based transplantation therapies, large numbers of hepatocytes need to be prepared and used as donor cells. In addition, for screening of drugs and studies on the mechanisms of liver diseases, hepatocytes should be functionally maintained in culture with the ability to proliferate. However, it is difficult not only to isolate many hepatocytes from patients with liver diseases, but also to maintain multiple hepatocyte properties in culture. Thus, for realization of cell-based regenerative medicine for liver disorders and research on the pharmacological effects of drugs and mechanisms of liver diseases, many studies involving the generation of functional hepatocyte-like cells from non-hepatic cells are now in progress. Recently, in addition to embryonic stem cells, induced pluripotent stem (iPS) cells have been considered as the most likely source of hepatocyte-like cells, and many studies are actively underway to evaluate the utility of stem cell-derived hepatocyte-like cells [1] [2] [3] [4] [5] [6] .
There is, however, another approach being investigated.
Direct cell-fate conversion of one cell type into another cell type without going through the iPS cell state is known as "direct reprogramming", and is currently being extensively studied worldwide as a new technology for future innovative medicine. We previously reported that the introduction of genes encoding Hnf4α plus Foxa1, Foxa2, or Foxa3 into mouse fibroblasts enabled their direct conversion into hepatocyte-like cells, termed iHep cells 7) . The iHep cells possessed multiple hepatocyte-specific features and could repopulate hepatic tissues after transplantation into the livers of fumarylacetoacetate hydrolase-deficient mice, a mouse model of hereditary tyrosinemia type I 7) . Moreover, we recently showed that iHep cells had the properties of hepatocytes in lipid metabolism, including lipid synthesis from fatty acids, cytoplasmic accumulation of lipid droplets, lipid secretion into the culture medium, and responsiveness to lipid metabolism improvers, even after culture for a relatively long period 8) . Thus, it is expected that the direct reprogramming of fibroblasts to iHep cells should be studied in greater detail, and that this new technology should be improved to provide iHep cells applicable to the fields of medical science and drug discovery research, as an alternative to hepatocytes. 
Materials and Methods

1)Induction of iHep cells from MEFs
We induced direct conversion of MEFs into iHep cells as described previously 7) . Some modifications were added to the methods as described below. In the production of recombinant retroviruses, we used PLAT-E cells for transfection of plasmid DNA 9) . After the retrovirus infection, MEFs were cultured in our hepato-medium containing 20 ng/mL hepatocyte growth factor (PeproTech, Rocky Hill, NJ, USA) and 20 ng/mL epidermal growth factor (Sigma-Aldrich, St. Louis, MO, USA).
2)Live-cell imaging analysis
After MEFs were infected with the retroviruses expressing Hnf4α and Foxa3, the culture dishes were set on a Nikon BioStation IM (Nikon, Tokyo, Japan), and subjected to live-cell imaging analyses for 8 days at 37℃ under 5% CO2. Snapshots were obtained from the movies using NIS Elements software (Nikon).
3)Immunofluorescence staining and gene expression analysis
Immunofluorescence staining and qPCR analyses were conducted as described previously 7) . We used a rat antithymus cell antigen (Thy)-1 antibody (BioLegend, San Diego, CA, USA) to examine Thy-1 expression.
Results
1)Live-cell imaging analysis of the conversion of fibroblasts into epithelial-like cells
In this study, we analyzed the early stage of the direct conversion of MEFs into iHep cells in detail. As shown in Figure 1 , we observed the morphology of MEFs using a live-cell imaging system for 8 days after infection with the retroviruses expressing Hnf4α and Foxa3 . We also performed immunofluorescence staining for E-cadherin and albumin, which are markers of epithelial cells and The live-cell imaging analyses revealed that normal MEFs became flattened, increased in size, and gradually became senescent, while no epithelial-like cells were observed during the analysis for 8 days ( Fig. 2A ). However, MEFs expressing exogenous Hnf4α and Foxa3 began decreasing their size at 36 h after the retrovirus infection, and small, round-shaped cells appeared to increase during culture ( Fig. 2B) . At 72 h after the retrovirus infection, we observed compact cell-cell adhesion in the increased small, round-shaped cells, and they began to form small clusters of epithelial-like cells (Fig. 2B) . The epithelial-like cells continued proliferation and eventually formed large clusters, and the small clusters were also bonded to each other (Fig. 2B) . These data from the live-cell imaging analyses demonstrated that MEFs could initiate conversion into epithelial-like cells within 2 days after infection with the retroviruses expressing Hnf4α and Foxa3, and that these cells could actively proliferate to form epithelial clusters in culture. Interestingly, almost all E-cadherin-positive cells that appeared at 2 days after the retrovirus infection lacked the expression of the fibroblast marker Thy-1 (Fig. 4) . The data obtained from qPCR analyses also showed that the expressions of E-cadherin, albumin, and AFP were detected in the MEF cultures at 2 days, 1 day, and 1 day after the retrovirus infection, respectively, and thereafter increased continuously in a time-dependent manner (Fig. 5 ). Taken together, direct conversion of MEFs into epithelial-like cells 
2)Rapid induction of the expressions of markers for epithelial cells and hepatocytes in cultures of
retrovirus-infected MEFs
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Discussion
In our previous paper, we reported that clusters of Similar to the case for iHep cells, it was reported that direct conversion of MEFs into neuron-like cells and cardiomyocyte-like cells began within a couple of days after the introduction of cell lineage-specific factors 10, 11) . Although dependent on the methods used, conversion of MEFs into iPS cells was also initiated within several days after the introduction of defined transcription factors 12) . However, obtaining functionally differentiated cells from iPS cell cultures requires a relatively long time for the induction and selection of these cells. Thus, if we could use the direct reprogramming technology, the time required to yield the required cells would be greatly shortened. In actual medical settings, the desired numbers of cells required for particular treatments should be prepared as soon as possible at low cost, and thus, the technology for direct reprogramming will be beneficial as one of the next-generation therapies. We expect that this new technology will be improved to provide safe and increasingly functional cells that can be applicable to the fields of medical science and drug discovery research.
